| Watchers | 244 |
| 52-Wk Low | 609.15 |
| 52-Wk High | 1,108.35 |
| Market Cap | 178.23B |
| Volume | 4,953.00 |
| 52-Wk High | 1,108.35 |
| 52-Wk Low | 609.15 |
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. NATCO Pharma Ltd. market cap is 178.23B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. NATCO Pharma Ltd. 52 week high is 1,108.35 as of May 18, 2024.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. NATCO Pharma Ltd. 52 week low is 609.15 as of May 18, 2024.
NATCO Pharma Ltd. stock price today is 999.55.
NATCO Pharma Ltd. stock price yesterday was 993.95.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. NATCO Pharma Ltd.’s P/E ratio is 14.04.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. NATCO Pharma Ltd. P/B ratio is 3.3649.
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. NATCO Pharma Ltd.'s EBITDA is 9.04.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. NATCO Pharma Ltd. 50-day moving average is 987.58.
NATCO Pharma Ltd. has 4,491 employees.